Lymphocyte membrane antigen expression and intracellular cytokine patterns in an asymptomatic patient with persistently high serum levels of IgE

Annals of Allergy, Asthma and Immunology

Volumn 83, Issue 2, 1999, Pages 144-148

  Krampera, Mauro ^a   Antico, Andrea ^b   Vinante, Fabrizio ^a   Morosato, Lorella ^a   Pizzolo, Giovanni ^a,c  

^a UNIVERSITY OF VERONA   (Italy)

^b Ospedale Civile di Asola   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN E; MEMBRANE ANTIGEN;

AGED; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; FLOW CYTOMETRY; HUMAN; HYPEREOSINOPHILIA; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOPHENOTYPING; INTRACELLULAR KILLING; KILLER CELL; LYMPHOCYTE COUNT; LYMPHOCYTE MEMBRANE; MALE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0032793544     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62626-9     Document Type: Article

References (26)

1. Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulin E and undue susceptibility to infection. Pediatrics 1972;49:59-70.
2. Leung DYM, Geha RS. Clinical and immunologic aspects of the hyperimmunoglobulin E syndrome. Hematol Oncol Clin North Am 1988;2:81-100.
3. Hill HR, Quie PG. Raised serum IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet 1974;1:183-187.
4. Herrod HG, Erffmeyer JE, Valenski WR. Elevated in vitro IL-4 production in a patient with elevated serum IgE. Ann Allergy 1994;73:444-448.
5. Del Prete G, Tiri A, Maggi E, et al. Defective in vitro production of γ-interferon and tumor necrosis factor-α by circulating T cells from patients with the hyper-immunoglobulin E syndrome. J Clin Invest 1989;84: 1830-1835.
6. Rousset F, Robert J, Andary M, et al. Shifts in interleukin 4 and interferon γ production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J Allergy Clin Immunol 1991;87: 58-69.
7. Paganelli R, Scala E, Capobianchi MR, et al. Selective deficiency of interferon gamma production in the hyper IgE syndrome. Relationship to in vitro IgE synthesis. Clin Exp Immunol 1991;84:28-33.
8. Mosmann R, Subash S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996;17: 138-146.
9. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787-793.
10. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997;18:263-6.
11. Jung T, Schauer U, Heusser C, et al. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993;159:197-207.
12. Durkop H, Latza U, Hummel M, et al. Molecular cloning and expression of a new member of the nerve growth factor family that is characteristic for Hodgkin's disease. Cell 1992;69: 421-427.
13. Armitage RJ. Tumor necrosis factor receptor superfamily members and their ligands. Curr Opin Immunol 1994;6:407-413.
14. + T cells by IL-4 and IFN-γ. J Immunol 1997;158:2090-2098.
15. Annunziato F, Manetti R, Cosmi L, et al. Opposite regulatory effect of IL-4 and IFN-γ on CD30 and LAG-3 expression by activated human naive T cells. Eur J Immunol 1997;27: 2239-2244.
16. + T cells producing Th2-type cytokines. FASEB J 1995;9:81-86.
17. Romagnani S, Del Prete G, Maggi E, et al. CD30 and type 2 T helper (Th2) responses. J Leuk Biol 1995;57: 726-730.
18. + lymphoma. Haematologica 1995;80:357-366.
19. D'Elios MM, Romagnani P, Scaletti C, et al. In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells. J Leuk Biol 1997;61:539-544.
20. Chilosi M, Facchetti F, Notarangelo LD, et al. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome. Evidence for a Th2-mediated condition. Eur J Immunol 1996;26:329-334.
21. Pizzolo G, Vinante F, Nadali G, et al. High serum level of soluble CD30 in acute primary HIV-1 infection. Clin Exp Immunol 1997;108:251-254.
22. W. Knapp et al, eds. Leukocyte Typing IV, Oxford Univ Press, Oxford 1989.
23. + T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper-IgE. J Exp Med 1995;181:423-428.
24. Bengtsson A, Johansson C, Linder MT, Haliden G, van der Ploeg I, Scheynius A. Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation. J Leuk Biol 1995;58: 683-689.
25. Hamman D, Hilkens CMU, Grogan JL, Lens SMA, Kapsenberg ML, Yazdanbakhash M, van Lier RAW. CD30 expression does not discriminate between human Th1- and Th2-type T cells. J Immunol 1996;156: 1387-1391.
26. Pinto A, Aldinucci D, Gloghini A, et al. Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line. Blood 1996;88:3299-3305.